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Abstract: 
Background: Argyrophilic Nuclear organizer regions (AgNORs) 
are associated with proliferative activity and stands as a 
characteristic mark in the diagnosis of several neoplastic entities. 
Objective: To assess cellular proliferative activity using AgNOR in 
oral epithelial dysplasia and squamous cell carcinoma in toombak 
and non-toombak dippers in Sudan. 
Materials and Methods: The study is a hospital-based analytical 
correlation study. Sixty two biopsies of oral epithelial dysplasia and 
squamous cell carcinoma from 54 toombak and non-toombak 
dipper patients made the sample of this study. Biopsies were 
collected in labelled sterile containers from KTDH during the 
period June 2009 to March 2010. The lab work was carried out in 
the Oral Pathology laboratory, Faculty of Dentistry, University of 
Khartoum where the biopsy were fixed with neutral buffered 
formalin then embedded and serially sectioned. The sections were 
stained using H&E stained and then diagnosed. Other sections were 
stained with silver nitrate and then mean count of AgNOR obtained. 
Results:  The Mean AgNOR estimated in toombak dippers 
compared to non-toombak dippers provided statistically significant 
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information that toombak dipping is associated with less cellular 
proliferation. Furthermore, the mAgNOR values showed a gradual 
increase from well differentiated squamous cell carcinoma to 
moderately differentiated SCC and finally to the poorly 
differentiated SCC which showed the highest mean. 
Conclusion: The mean AgNOR count appears to be a useful 
diagnostic tool to distinguish between different histopathological 
grades of oral squamous cell carcinoma and can be used as a 
supportive tool to routinely performed Hemotoxylin and Eosin 
staining. Further prospective studies with larger number of cases are 
needed especially for oral epithelial dysplasia to have more 
significant conclusions. 
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1.1 Introduction: 
The cellular proliferation assessment carries important information about 
diagnosis and prognosis. Increase in the proliferation rate is probably one 
of the first indicators of malignant transformation[1]. 
In the last two decades, silver staining of nucleolar organizer region-
associated proteins (AgNORs) has been widely used in tumor pathology 
both for diagnostic and for prognostic purposes. AgNOR is one of the 
techniques used to assess cellular proliferation; it stains the proteins 
associated with the nucleolar organizer regions (NORs)[2-4]. NORs are 
specific portion of DNA during the protein synthesis they are transcribed 
into ribosomal RNA (rRNA) by the enzyme RNA-polymerase 1. The 
protein synthesis is an essential step in the process of cellular 
proliferation.  On staining the tissues with silver stain, the reaction 
product represents the Argyrophilic nucleolar organizer regions 
(AgNORs) which can be visualized by the light microscope as well 
defined black spots that can be counted[5, 6]. 
Drenzini and Trere revealed that the higher the number of NORs, the 
lower the duration of the cell cycle and the higher is the rapidity of cell 
proliferation. So the quantitative analysis of NORs presents an excellent 
indicator of the proliferation activity of the cells and a valuable diagnostic 
tool [6]. AgNOR counts reported for the same tumor type may differ and 
this is due to different methods of AgNOR staining and quantification[7]. 
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AgNOR counts include two methods; a/  the conventional manual 
counting, include the mean count (mAgNOR) and the pAgNOR 
(percentage of nuclei with specified AgNOR count), and b/  the 
morphometric image analysis ( used to assess mAgNOR, pAgNOR , 
shape, contour, size as well as the distribution of AgNOR inside the 
cell)[7]. 
Different risk factors including toombak may produce wide range of 
changes in oral mucosa. Several previous studies revealed variable 
mucosal changes associated with toombak dipping.[8-11] 
The purpose of this study is to assess the cellular proliferation activity 
using mean AgNOR count in oral epithelial dysplasia and squamous cell 
carcinoma in toombak and non-toombak dippers. 
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1.2 Review of Literature: 
1.2.1 Argyrophilic Nucleolar Organizer Regions (AgNORs): 
Argyrophilic nucleolar organizer regions (AgNORs) are loops of 
ribosomal RNA (rDNA) normally found in the nucleoli of cells. In the 
human genome NORs are located on short arm of five acrocentric 
chromosomes (13, 14, 15, 21 & 22). The nucleolar organizer regions can 
be visualized by staining with silver nitrate solution under prescribed 
conditions.  They have attracted much attention because of claims that 
their frequency within the nucleus has been significantly higher in 
malignant cells than in normal cells, and that they produce a very useful 
mean for examination of nucleolar structure and variations in nucleolar 
activity.[12, 13] 
AgNORs are typically found aggregated within one or two nucleoli 
during interphase in normal cells. The number of AgNORs visualized 
depends upon the number of AgNOR bearing chromosomes in the 
Karyotype, RNA transcriptional activity and stage of the cell cycle as the 
nucleolus disperses before mitosis and reorganizes afterwards[6].  
These properties of NORs have led to their use as diagnostic tools in 
various malignancies for evaluation of their prognosis and 
aggressiveness. Several studies revealed a rapidly dividing tumor has a 
greater proportion of cells in early stages of G1 phase before individual 
NORs have associated and are more likely to be observed in greater 
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numbers. Conversely, tumors with low rate of cell proliferation are more 
likely to display a single NOR[5]. 
1.2.2 Oral dysplasia and squamous cell carcinoma: 
Normal oral squamous epithelium is a tissue in which cells progressively 
mature when moving from the basal cell layer into the upper superficial 
layer. Histopathological grading of epithelial dysplasia and SCC is based 
on the cellular deviation from this regular outline. It is thought that the 
greater the cellular changes in a lesion compared to normal, the more 
aggressive  will be its clinical behavior [14]. 
Malignant and dysplastic growth is a process in which the normal tissue 
characteristics are lost while certain molecular structures become 
obvious. These changes may possibly be considered as tumor markers 
which are used in diagnosis or to observe the effects of treatment [15]. 
Tsuji et al, have reported that cellular proliferation in oral premalignant 
lesions was significantly higher than those in normal mucosa and 
suggested that cellular proliferation is correlated with the degree of 
severity of dysplasia. It is considered that the severity of the dysplasia is 
linked to the degree of probability in the development of malignancy.  
Therefore, it seems likely that severe EDs have higher potential to 
develop into malignancy[16]. 
Oral squamous cell carcinoma is a malignant neoplasm arising from the 
mucosal epithelium of the oral cavity. It represents the third most 
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common form of malignancy in the developing countries whilst in 
developed countries it is the eighth most common[17, 18]. Oral squamous 
cell carcinoma is recognized as a disease resulting from genetic damage, 
leading to uncontrolled cell proliferation of damaged cells[19]. It is by far 
the commonest malignancy associated with oral cavity, and its morbidity 
and mortality remains at alarmingly high rates [17, 18]. 
Recent studies on detection and diagnosis of epithelial dysplasia and SCC 
of the oral cavity focused mainly on the tumor markers. Markers of cell 
proliferation are applied to predict progression to malignancy in cases 
where clinical and pathological parameters fail to verify its 
aggressiveness [20, 21]. 
1.2.3 Association between Toombak, oral dysplasia and malignancy: 
Tobacco that is placed into the oral cavity is termed smokeless tobacco 
(SLT), which is used in western countries (USA and Norway), Asia 
(Yemen and India) as well as in Sudan. A wide variety of mucosal lesions 
such as dysplasia and hyperkeratosis has been shown to be associated 
with SLT. There is strong belief that carcinoma might develop in these 
lesions [22-24]. Studies proved that SLT contains carcinogens such as N- 
nitrosamine.  SLT use is also linked to the etiology of pharyngeal and 
other body cancers. It is also etiologically related to tooth abrasion and 
periodontal diseases[25, 26]. 
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Toombak a traditional form of SLT use in Sudan, is composed of a 
mixture of sodium bicarbonate, tobacco and water. It is placed in the oral 
vestibule or in the floor of the mouth where it stays in direct contact with 
oral mucosa for a long time. Chemical analysis of toombak compared to 
US and Swedish commercial snuff brands showed that it contains at least 
100- fold higher concentration of the tobacco specific N-
nitrosamines(TSNA), which is the most potent, abundant and powerful 
carcinogens in snuff.[27-29] Studies revealed a relationship between 
toombak dipping and oral ED and SCC.[10, 30] 
1.2.4 Application of AgNOR to various head and neck tumors: 
AgNOR techniques have been applied to various reactive, benign, 
premalignant and malignant lesions of the body as well as head and neck 
lesions. 
Egan et al. (1988) examined 19 transitional nose tumor using AgNOR 
quantification. They found that the mAgNOR count for benign 
papillomas of the nose was 2.2± 0.35, for  benign tumors which 
undergoing  malignant changes was 3.25±0.35, for normal respiratory 
epithelium was 1.93± 0.13 and for frank carcinoma was 6.22±1.26. Their 
results revealed that a tumor undergoing  malignant changes could easily 
be distinguished from the benign and frank malignant counterpart using 
AgNOR count[31]. 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 7 
 
Morgan et al. (1988) applied AgNOR staining technique to 35 cases of 
salivary gland tumors, 13 were benign and 22 malignant. The result 
showed that there was a highly significant difference between the mean 
number of AgNORs in benign and malignant tumor. They proposed that 
AgNOR staining technique is of diagnostic help in distinguishing 
between these salivary gland tumors[32]. 
 Yazdi and Taghavi (2005) used AgNOR staining to estimate the grade of 
malignancy in the head and neck Non-Hodgkin’s lymphoma (NHL). 
Forty one cases of paraffin embedded specimens of NHL were selected 
and classified by the working formulation system, then examined by the 
AgNOR method.  The AgNOR count was 1 -2 per cell, 2 -3 per cell, and 
more than 4 per cell in low-grade, intermediate- grade  and high- grade  
tumors respectively. Analysis of the results showed considerable 
differences in the mean AgNOR count in the 3 groups. The authors 
concluded that AgNORs is a reliable method to be applied in grading of 
the head and neck NHL[33]. 
Adeyemi et al. (2006) assessed the utility of AgNOR staining in 
categorizing and studying the prognosis of salivary gland tumors. They 
used AgNOR staining technique in 27 malignant salivary gland tumors, 
16 benign salivary gland tumors, and 6 chronic sialadenitits. The results 
demonstrated that mAgNORs for inflammatory lesions and begnin 
lesions were less compare to that of malignant neoplasms. There were no 
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significant variations between mAgNORs of different specific 
histological types & grades of malignant neoplasm. Also no relation was 
found between mAgNOR counts and the clinical course of benign and 
malignant neoplasms. The authors concluded that the AgNOR technique 
is valuable only in differentiating between the benign and the malignant 
neoplasm and has no prognostic significant[34]. 
Mahajan and his coworkers (2008) made a comparison between 
aggressive and nonaggressive central giant cell lesions on the base of 
clinical and histological behavior using AgNOR staining.  They revealed 
that aggressive central giant cell lesions have higher score for mean 
AgNOR than nonaggressive lesions, in both mononuclear and 
multinuclear cells[35]. 
Santos and his colleagues (2009) studied the proliferative activity present 
in luminal and mural areas of mural unicystic ameloblastoma (MUA), 
conventional ameloblastoma (CA) and dentigerous cyst (DC). The 
investigators compared the biological behavior of these tumors using 
AgNOR quantification. The mean AgNOR of luminal proliferation areas 
for MUA (1.68±0.13) was significantly lower than for the mural 
proliferation areas of MUA (2.02±0.22) and that of the CA (2.06±0.22), 
whereas it was not statistically different from that of the DC 
(1.83±0.32)[36]. 
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1.2.5 Application of AgNOR to oral ED and SCC: 
Sano et al. (1991) carried out a study using AgNOR technique in 39 cases 
of oral squamous cell carcinoma. These cases were divided into poor 
prognostic group (n = 19) and good prognostic group (n = 20). Then a 
comparison between AgNOR counts and histological grading, and also a 
correlation between AgNOR counts and prognosis was made. The 
mAgNOR count was (6.39 ± 1.67) in grade 1 carcinomas, (9.74 ± 1.72) in 
grade 2 and Grade 3 was (6.19 +/- 2.37). Regarding the prognosis, in poor 
prognostic group the mAgNOR count was higher compared to good 
prognostic group. They concluded that high AgNOR counts are highly 
suggestive of poor prognosis in oral squamous cell carcinoma[37]. 
Cabrini and his co-workers (1992) evaluated the distribution, volume, 
number and shape of AgNOR in the different strata of 10 human normal 
oral epithelium and 8 papillomas and 6 squamous cell carcinomas using 
microphotographs. The AgNOR parameters revealed significant 
differences between normal mucosa, papilloma and squamous cell 
carcinoma[38]. 
Khan et al. (1993) analyzed 36 premalignant lesions of the oral cavity 
using flow cytometry and AgNOR enumeration. The result showed 
positive correlation between them, but the authors concluded that both 
techniques are not  useful  as diagnostic aid in grading oral mucosal 
dysplasia[39]. 
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Warnakulasuriya and Jhonson (1993) had quantified AgNORs in 40 oral 
mucosal biopsies consisting of benign, reactive, dysplastic and 
carcinomatous lesions. The result revealed mAgNOR counts were greater 
in carcinomas (8.37 ± 6.11) than in epithelial dysplasias (5.61 ± 4.63) or 
benign keratoses (4.51 ± 2.57). Benign keratosis showed single, double or 
few AgNOR, while SCC showed multiple small scattered AgNORs[40]. 
Schwint et al. (1994) investigated oral epithelium adjacent to SCC. They 
compared them to normal mucosa epithelium and to the carcinomatous 
parenchyma using AgNOR morphometric analysis. Their results showed 
differences in AgNOR parameters between normal mucosa and mucosa 
adjacent to SCC. They concluded that AgNOR parameter showed 
considerable differences in epithelium close to SCC in absence of cellular 
atypia[41]. 
Pillai et al. (1994) studied the mean AgNOR in normal epithelium, 
premalignant and malignant lesions of the oral mucosa. The mean 
AgNOR of SCC (4.65±0.98) was the utmost compared to leukoplakia 
(2.38±0.47) and normal epithelium (1.53±0.39). Regarding SCC, the 
spindle variant and poorly differentiated SCC had higher mAgNOR 
compared to well differentiated SCC. Speckled leukoplakia had the 
highest mAgNOR count in oral leukoplakias, while the homogenous 
leukoplakia showed the lowest mAgNOR counts. The dysplastic and non-
dysplastic leukoplakia showed no differences but there was a 
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considerable difference between dysplastic leukoplakia and normal oral 
mucosa. It is concluded that there is an association between  tumor 
progression and mAgNOR count[42]. 
Kobayashi et al. (1995) examined the proliferative activity of leukoplakia 
without dysplastic change (LP), ED and SCC in the oral mucosa using 
PCNA immuno-staining, AgNOR and mitotic figure. The Mean AgNOR 
was significantly different between ED and SCC but there was no 
considerable association between mAgNOR and other indices. They 
concluded  that the severity of the oral ED cannot be evaluated using 
AgNOR[43]. 
Muzio et al. (1997) studied samples of 21 oral leukoplakia (where 13 low, 
4 moderate and 4 had sever degree of dysplasia) and 5 cases of 
microinvasive carcinomas. All these samples shown were to be associated 
with HPV. The researchers studied new parameters of NORs which are 
VNOR, TVNOR and RI AgNOR which mean single volume of nucleus, 
total volume per nucleus and roundness index respectively.  The 
investigators found only TV NOR   to be  useful in oral dysplasia , a  high 
score of  it  represents a risk marker with worse prognosis, while  the rest 
of the parameters showed no  value in  differentiating between the 
different lesions[44]. 
Xie et al. (1997) investigated 51 oral squamous cell carcinoma, 10 
dysplasia and 8 normal epithelium using mAgNOR and PAgNOR. The 
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result showed that there were significant differences between normal 
epithelium and dysplasia and between dysplasia and SCC. No correlation 
was found between AgNOR counts and the clinical staging of SCC. The 
overall means for mAgNOR and pAgNORs were correlated with the 
disease-free period and survival rate. AgNOR enumeration, in particular 
pAgNOR 1, appears to be a useful tool in distinguishing between normal 
epithelium, dysplasia, and SCC of the oral cavity. In their study the 
authors concluded that AgNOR counts were strong prognostic markers 
for patients with squamous cell carcinoma[45]. 
J. Piffko et al. (1997) using AgNOR morphometric analysis  studied the 
invasive front of SCC of the floor of the mouth and tongue (80 archival 
cases)  and related it  to some clinicopathological parameters, including 
clinical staging, clinical course, surgical staging and histological grading 
and patient's prognosis . All the AgNOR parameters showed a statistically 
significant association with the clinical course of the disease. AgNOR-
area was found to have the strongest association, and the mAgNOR count 
could be used to estimate both the disease-free period and overall 
survival. The authors concluded that morphometric analysis of AgNOR is 
fundamental for an objective and reproducible AgNOR judgment. 
Moreover , They recommended AgNOR  to be used as a supplementary 
diagnostic and prognostic aid in oral SCC[46]. 
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Piffko et al. (1997) evaluated the cells at the invasive tumor front of 94 
Oral SCCs using histopathological grade and AgNOR technique. A 
significant association was observed between the AgNOR 
histopathological grade, clinical stage and prognosis. High malignant 
growth potential at tumor front was observed along with the AgNOR 
count. It was concluded that AgNOR should be used to evaluate the 
proliferation rate at the invasive tumor front[47]. 
Chatterjee et al. (1997) examined the mAgNOR in 39 cases of SCC some 
with and others without human papilloma virus (HPV) infection. No 
significant difference between AgNOR counts of the HPV-positive 
samples (7.15±2.13) and the HPV-negative ones (6.16±1.89) was found. 
Lesions with HPV type 16/18 infection only had less AgNOR count 
compared to those infected with multiple HPV.  The AgNOR count was 
significantly different regarding the different grades of SCC. The Mean 
AgNOR in Poorly differentiated SCC was 10.5±0.54, in moderately 
differentiated SCC was 7.31±1.07 and was 5.I2±0.85 in well-
differentiated SCC. Furthermore, a linear correlation was shown between 
mAgNOR and bromodeoxyuridine labeling index[48]. 
de Rosa et al. (1999) carried out a study to evaluate  AgNORs , PCNA, 
p53, and c-myc expression, on a total of 40 lower lip  lesions including; 
30 cases of SCC, 7 cases of  actinic cheilitis, 3 cases of  leukoplakias and 
4 cases of SCC with nodal metastases.  Their results revealed that the 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 14 
 
numbers of AgNORs  as well as their size in addition to the percentage of 
PCNA-positive cells were sensitive markers to differentiate between 
potentially malignant lesions and SCC[49]. 
Xin Xie et al. (1999) studied 85 cases of SCC of the tongue to evaluate 
the prognostic effect of proliferative and apoptotic markers. The 
proliferative markers were the Ki67 immunhistochemical marker and the 
AgNOR counts (mAgNOR and pAgNOR). While the apoptotic markers 
were the apoptotic index (AI) and the Bax immunohistochemical marker. 
They observed that a combination of proliferative and apoptotic markers 
is a stronger predictor than the individual parameters in SCC of the 
tongue [50]. 
L. Yue et al. (1999) studied 67 biopsies of tongue SCC and correlated 
AgNOR to the clinico-pathological parameters, PCNA marker and to the 
outcome of the disease. There was significant statistical difference in the 
mAgNOR between the SCC and the normal oral epithelium. The 
mAgNOR in cases of SCC with positive lymph node involvement (stages 
III, IV) was statistically higher than in those cases with negative lymph 
nodes (stages I, II), particularly   tumors which were diffuse and invasive 
and also tumors which were histologically grade III. A significant 
association between the AgNOR and the results of PCNA was found.   
The 5- years' survival was 63.5% in the group with high AgNOR counts 
and 86.0% in those with low AgNOR counts and the difference was 
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statistically significant. These results proposed  that  the AgNORs may 
reveal the grade of malignancy in tongue SCCs and also the cellular 
proliferation[51]. 
Costa and his fellow workers (1999) performed a study on 15 cases of 
oral SCC correlating between the number of AgNORs, Ki-67 and PCNA 
immunohistochemical markers. They enumerated the number of AgNORs 
in cells with PCNA positive and PCNA negative ones as well as in Ki-67-
positive and-negative cells. Their results revealed a higher mAgNOR in 
PCNA and Ki-67-positive cells compared to PCNA- and Ki-67-negative 
cells. So, they concluded that a correlation exists between cell 
proliferation and mAgNOR in OSCC[52]. 
In Brazil, L.M. Fonseca and M.A. Carmo (2000) conducted a research to 
compare between hyperplasias, papilomas and OSCCs using AgNOR 
technique. The sample size was 39 distributed as follow: 10 papillomas, 
10 inflamatory hyperplasia, 7 well differentiated OSCC and 12 poorly 
differentiated OSCC. They found that AgNORs shape in hyperplasia and 
papilloma are more regular compared to OSCC where there are different 
shapes. On the other hand, the hyperplasia showed the least mAgNOR 
count (1.98±1.25) followed by the papilloma (3.15± 0.58), while the 
OSCC showed the highest mAgNOR counts (6.56±1.25). The authors  
concluded that cellular proliferation ratio is greater in papilloma 
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compared to hyperplasia & lesser in papilloma when compared to 
OSCC[53]. 
Chattopadhyay et al. (2002) studied the mAgNOR in normal oral 
epithelium (41 cases), dysplastic leukoplakia (26 cases), non-dysplastic 
leukoplakia (25 cases) and SCC (51 cases). Their results revealed that 
mAgNOR counts increased gradually from normal epithelium to non-
dysplastic to dysplastic leukoplakia to SCC. The mAgNOR of a 2.37 
count cut-point is used to differentiate between dysplastic and non-
dysplastic leukoplakia. The authors  concluded that AgNOR should be 
used as a valuable  marker for diagnosis as well as differentiate between 
dysplastic and non-dysplastic leukoplakia[54]. 
Spolidorio et al. (2002) studied different NOR parameters in normal oral 
mucosa (12 cases), dysplasia (23 cases) and microinvasive carcinoma (12 
cases). NOR parameters were evaluated using image analyzer 
(morphometric analysis). The results were different for normal mucosa, 
dysplasia and microinvasive carcinoma. The investigators concluded that 
an increase of NOR is associated with the progression of the disease and 
probably reflects the degree of cellular proliferation and malignancy. [55] 
Cano et al. (2002) examined 26 cases of mild ED, 15 cases of moderate 
ED and 57 cases of SCC of the oral cavity to determine the prognostic 
importance of AgNORs and ki-67. Their results showed that in SCC the 
AgNOR count and Ki-67 positive cells were significantly higher than in 
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ED. No significant association between AgNOR counts and Ki-67 
immunohistochemical marker was found. In conclusion, they suggested 
that the AgNOR tissue marker can be used as a routine complementary in 
histopathological examination[56]. 
Ray et al. (2003) compared the mAgNOR count to H & E staining in 52 
cases of oral leukoplakia (dysplastic and non-dysplastic leukoplakia). The 
mAgNOR cut-point of 2.37 was considered as a cut-point marker as was 
the case in some previous reports. The result showed that two methods 
disagreed in 37% of the cases, and a high mAgNOR count was observed 
in both non-dysplastic and dysplastic leukoplakia. They concluded that 
mAgNOR count can be utilized as a valuable method in definitive 
diagnosis of ED[13]. 
Xie et al. (2004) investigated the prognostic significance of Bag-1 and 
their relationship with ki-67 marker and AgNOR parameters on 85 tongue 
SCCs. Their results revealed a significant association between Bag-1 
expression, Ki-67, mAgNOR and the pAgNOR. They concluded that the 
prognosis of tongue SCC can be evaluated using a combination of 
apoptotic and proliferative markers [57]. 
Guler et al. (2005) studied 26 patients with oral and oropharyngeal SCCs 
and their adjacent normal mucosa for their expression of Fas and Fas 
ligand and then correlated these markers with the clinical stage, 
histopathological grade and AgNOR count. Immunohistochemical 
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expression of Fas and/or Fas-L was observed in 17 (65%) of the tumors. 
A statistically significant association between Fas/Fas-L expression and 
the clinical stage was found. All AgNOR parameters were significantly 
increased in the SCC cells compared to the adjacent squamous epithelial 
cells. The AgNOR parameters were significantly correlated with Fas/ 
Fas-L expression. In addition, the AgNOR parameters showed 
statistically significant association with the grading of tumors[58]. 
Manu et al. (2006) carried out a study using AgNOR technique in 50 
cases of SCC of the upper Aero-digestive tract. They compared AgNOR 
parameters with the histological grade and also evaluated the significance 
of AgNOR technique in expecting the progress of the tumor. The result 
showed that the mAgNOR of the normal squamous epithelium was 1.56, 
of the well differentiated SCC was 3.29, of the moderately differentiated 
SCC was 4.29 and that of the poorly differentiated SCC was 5.21. They 
concluded that the AgNOR technique can be utilized as a supportive tool 
to the routinely H& E staining and also the AgNOR technique may help 
in the prediction of prognosis in addition to the management of SCC. 
Because of the small size of their sample, the authors  recommended the 
conduction of further studies using  larger sample sizes[59]. 
Eslami B et al. (2006) assessed the AgNOR technique in SCC of larynx 
(21 cases), oral SCC (28 cases) and most common salivary gland tumors 
(36 cases).  Their results revealed that mAgNOR in SCC group is higher 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 19 
 
compared to dysplastic and normal epithelium and as well the 
mucoepidermoid carcinoma and adenoid cystic carcinoma showing 
higher mAgNOR compared to pleomorphic adenoma and normal salivary 
gland tissue. They concluded that AgNOR is a valuable tool to be used as 
an adjunct in the diagnosis of malignant and dysplastic lesions as well as 
in malignant and benign salivary gland tumors[60]. 
Teresa et al. (2007) studied the use of AgNOR technique and Ki-67 
markers in the proliferation rate of oral lesions. Their sample consisted of 
fibrous inflammatory hyperplasia (20 cases), non-dysplastic leukoplakia 
(22 cases), dysplastic leukoplakia (18 cases) and OSCC (23 cases). Their 
results showed that Ki-67 is an excellent marker for detecting the growth 
rate among all these oral lesions. Comparing the AgNOR parameters the 
investigators pointed out that the morphometric analysis had better results 
than the numerical one. There was a significant correlation between 
AgNOR parameters and ki-67 results. They concluded that the 
proliferative rate of SCC can be assessed using a combination of Ki-67 
and morphometric AgNOR analysis[61]. 
Padovani et al. (2007) carried out a double blind study using 
morphometric analysis of AgNOR method in biopsies from patients with 
tongue SCC. The morphometric analysis included the study of AgNOR 
and other nuclear parameters. The authors found that morphometric 
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analysis of AgNOR can help in the prediction of prognosis as well as in 
treatment planning [62]. 
Chattopadhyay et al. (2008) assessed 100 cases of oral leukoplakia to 
calculate their mAgNOR count as well as to ascertain a cut-point mean 
AgNOR count for ED.  Their results showed that the mAgNOR count of 
2.3 should be used as a cut-point to differentiate between mild and 
moderate dysplasia. They concluded that this approach will provide a 
cheap, significant , ultimate, reproducible and reliable diagnostic tool  for 
ED [63]. 
Elangovan (2008) conducted a research to evaluate AgNOR in 
inflammatory lesions (5 cases), premalignant (10 cases), SCC (10 cases) 
and normal oral mucosa (2 cases).There was a difference in the   AgNOR 
Mean between  the normal mucosa, inflammatory lesions, and SCC, 
while there was no significant differences of the mAgNOR between the 
premalignant lesions and the normal mucosa. The AgNOR in the normal 
mucosa and the inflammatory lesion were uniform round or oval, in 
contrast to the AgNOR in the premalignant and malignant lesions which 
was irregular in shape and with variation in size. In SCC pleomorphic 
shapes of AgNOR were observed[64]. 
De Sousa et al. (2009) compared the cellular proliferation rate of oral 
lichen planus, epithelial dysplasia and OSCC (24 cases for each group) by 
using AgNOR technique and PCNA immunohistochemical marker. Their 
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results for PCNA positivity was 58.33% in oral LP cases, 83.33% in ED 
cases and 91.67% in oral SCC. The mAgNOR was in oral LP, ED and 
oral SCC (1.74±0.32), (2.42±0.62) and (2.41±0.61), respectively. It is 
concluded that  the cell proliferation rate for oral LP was less than that of  
the oral ED and oral SCC and this may possibly explain the low 
malignant transformation rate of LP [65]. 
Hildebrand et al. (2010) compared the proliferative activity of non-
dysplastic leukoplakias (10 cases of hyperkeratosis, 10 cases of 
acanthosis, 10 cases of hyperkeratosis with acanthosis) and with epithelial 
dysplastic (ED) leukoplakias (10 cases) and normal oral epithelium (10 
cases). The mAgNOR was different between these lesions. The rate of 
cell proliferation was different between different types of non-dysplastic 
leukoplakias ,showing a  higher rate of proliferation than  normal oral 
epithelium [66]. 
Ashraf et al. (2010) carried out a study to compare between the AgNOR 
technique and the immunohistochemical marker Ki67 in normal 
epithelium (10 cases), ED (10cases), primary SCC (26 cases) and 
metastatic SCC (18 cases). The percentage of Ki67 was increased 
significantly from normal epithelium to SCC and   is related also to the 
histological grade. The mAgNOR was higher in SCC than in ED and 
lower in normal epithelium than ED. The mAgNOR in SCC increased 
significantly according to the grade of SCC. Ki67 percentage and 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 22 
 
mAgNOR were significantly correlated. Ki67 is a gold standard method 
for evaluation of proliferation activity. The authors concluded that 
AgNOR correlate to the cellular proliferation rate but does not essentially 
point out malignancy[67]. 
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1.3 Justifications of this study: 
 
·  The technique of AgNOR is quantitative, simple and inexpensive. 
It is not very popular in this country and it is worthwhile to be 
introduced, at least in major research laboratories.  
· This is the first histopathological study to assess oral dysplasia and 
squamous cell carcinoma in toombak and non-toombak patients 
using the AgNOR technique. 
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1.4 Objectives: 
1.4.1 General objective: 
· To assess cellular proliferative activity using AgNOR in oral ED 
and SCC in toombak and non-toombak dippers in Sudan. 
1.4.2 Specific objectives: 
1. To determine cellular proliferative activity (using AgNOR) in oral 
ED and SCC in toombak and non-toombak dippers. 
2. To evaluate the relationship of cellular proliferative activity (using 
AgNOR) in oral ED and SCC in toombak and non-toombak 
dippers. 
3. To formulate AgNOR reference index using confidence interval to 
oral ED and SCC in toombak and non-toombak dippers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 25 
 
2. MATERIALS AND METHODS  
This is a hospital -based analytical correlation study. The material of this 
study was 62 oral ED and SCC lesions collected from 54 toombak and 
non-toombak dipper patients. All the patients were seen and treated at 
Khartoum Teaching Dental Hospital (KTDH), in the period June 2009 to 
March 2010. 
Inclusion criteria:  
Patients attended KTDH with oral epithelial dysplasia and SCC 
lesions who accepted to be treated in the hospital. 
Exclusion criteria:  
Patients who previously received radiotherapy and/ or 
chemotherapyto the head and neck region and patients with recurrent 
lesions. 
Data collection:  
The clinical information including age, gender, information about 
toombak dipping and other habits, clinical presentation, and site of 
the lesion were obtained (Questionnaire).       
Specimens were removed under local or general anesthesia, collected into 
labelled containers and fixed with 10% formalin and 0.17 ml phosphate 
buffer at pH 7. The fixed specimens were embedded into paraffin wax 
and serially sectioned at 2-3 micrometers. Sections were stained with 
routine haemotoxylin and eosin and then diagnosed and graded according 
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to  the WHO criteria 1997 [68].  The lesions examined include the 
following: 
1/ Verrucous hyperplasia: an exophytic overgrowth of well differentiated 
keratinized epithelium that is similar to Verrucous carcinoma but without 
the destructive, pushing border at its interface with the underlying 
connective tissue. 
2/ Epithelial dysplasia: Divided into mild, moderate and severe.  The 
changes occurring in epithelial dysplasia are listed below and the more 
prominent or more numerous they are, the more severe the grade of 
dysplasia. Histological changes that may contribute to a diagnosis of 
epithelial dysplasia include the following: 
§ Loss of polarity of the basal cells. 
§ The presence of more than one layer having a basaloid appearance. 
§ Increased nuclear-cytoplasmic ratio. 
§ Drop-shaped rete-ridges. 
§ Irregular epithelial stratification. 
§ Increased number of mitotic figures. 
§ Abnormal Mitotic figures. 
§ The presence of mitotic figures in the superficial half of the 
epithelium. 
§ Cellular and nuclear pleomorphism. 
§ Nuclear hyperchromatism. 
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§ Enlarged nucleoli. 
§ Loss of intercellular adherence. 
§ Keratinization of single cells or cell groups in the prickle cell layer. 
3/ Carcinoma in situ: A lesion in which the full thickness, or almost the 
full thickness, of squamous epithelium shows the cellular features of 
carcinoma without stromal invasion. 
4/ Squamous cell carcinoma: The grading of squamous cell carcinoma is 
generally based on the method originally described by Broaders, who 
took into account a subjective assessment of the degree of keratinization, 
cellular Pleomorphism, nuclear pleomorphism and mitotic activity. The 
grades are: 
Grade 1: Well differentiated: Histological and cytological features closely 
resemble those of the squamous epithelial lining of oral mucosa. There 
are varying proportions of basal and squamous cells with intercellular 
bridges; keratinization is a prominent feature; few mitotic figures are seen 
and atypical mitoses or multinucleated epithelial cells are extremely rare, 
nuclear and cellular pleomorphism is minimal. 
Grade 2: Moderately differentiated: This is a neoplasm with features 
intermediate between well differentiated and poorly differentiated. 
Compare with well- differentiated SCC, these have less keratinization and 
more nuclear and cellular pleomorphism; there are more mitotic figures 
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and some are abnormal in form; intercellular bridges are less 
conspicuous. 
Grade 3: Poorly differentiated: Histologically and cytologically there is 
only a slight resemblance to the normal stratified squamous epithelium of 
the oral mucosa. Keratinization is rarely present and intercellular bridges 
are extremely scarce; mitotic activity is frequent and atypical mitoses can 
readily be found; cellular and nuclear pleomorphism are obvious and 
multinucleated cells may be frequent. 
When the tumor shows different grades of differentiation, the higher 
grade determines the final categorization. 
5/ Verrucous carcinoma: A warty variant of SCC characterized by a 
predominantly exophytic overgrowth of well- differentiated keratinized 
epithelium having minimal atypia and with locally destructive pushing 
margins at its interface with underlying connective tissue. It has a distinct 
clinical and microscopic features as well as mode of behavior. The well 
differentiated, hyperplastic stratified squamous epithelium is organized 
into bulbous rete-ridges that exhibit little or no cytological atypia or 
mitotic activity. There may be a significant endophytic component and 
the invading margin is usually below the level of the surrounding mucosa. 
Deep surface invaginations are filled with keratin. The advancing 
epithelial border is broad and the basement membrane is generally intact. 
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2.3.3 AgNOR staining: The staining was performed using the one-step 
silver colloid method proposed by Ploton et al[2, 69]. The paraffin 
embedded sections were dewaxed in xylene and rehydrated through 
graded ethanol to distilled deionized water. The AgNOR solution was 
made by dissolving gelatin in 1g/dl aqueous formic acid to a final 
concentration of 2g/dL. One volume of this solution was mixed with two 
volumes of a 50g/dL aqueous silver nitrate solution to get the final 
solution for the staining procedure. The 4-micrometer thick sections were 
immersed in the final solution at room temperature in the dark for 45 
minutes, after which they were washed with distilled deionized water, 
dehydrated through graded ethanol to xylene and mounted in a permanent 
mounting medium.  
2.3.4 AgNOR counting:  Cases were evaluated for AgNOR by 
conventional counting method according to the AgNOR committee. 
The slides were evaluated using a multi viewing light microscope 
(Labomed co. ltd model CXR5, USA) with X 100 objective lens 
under oil immersion and a green filter to reduce chromatic aberration 
and increase the clarity of the AgNOR perimeters. Areas of necrosis 
and severe inflammation were excluded. The number of silver-
stained dots per cell was carefully enumerated.  
In each slide 5 microscopic fields were counted and 10 cells per field 
were randomly selected and counted (50 cells per slide). Nuclei 
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lacking AgNOR were not included in the cells counted for each 
tumor.  In cases where the dots stained as a ring structure by the 
silver nitrate method, they are counted as one. When an aggregation 
of dots could not be resolved into individual NORs by focusing, each 
cluster was counted as a single dot, as recommended by Crocker et 
al. and Trere`[7].  
The total AgNOR count in each section was determined, and this 
was correlated with the number of cells evaluated in order to obtain 
the mean (values per 50 cells.), and the standard deviation.  
2.3.5 Ethical clearance:  The approval for conducting this study was 
obtained from the ethics committee of KTDH & the Postgraduate 
Medical & Health Studies Board of the Faculty of Dentistry before 
commencing data collection. Patients who were eligible and willing to 
participate were comprehensively informed and received a full 
explanation. The patients were aware that they have to sign an informed 
consent or refuse to participate in the study. 
2.3.6 Data entry and analysis:  Data was entered and analyzed using 
the SPSS version 16.  Students T- test and analysis of variance 
(ANOVA) statistical tests were used. P value less than 0.05 was 
considered significant.                                                                                                                        
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Results: 
A total of 54 patients with 62 lesions of oral epithelial dysplasia and SCC 
made the material of this study with a mean age of 58.34 years (minimum 
27years and maximum 90 years). The male to female ratio was 69.35: 
30.65 % (43 male and 19 female) (Fig. 3.1, 3.2). 
Habit distribution among patients:  
Forty two patients out of 62 were toombak dippers (67.7%) and the rest 
were non dippers (20 patients, 32.3%). The non-smokers were 49 patients 
(79 %) and the smokers were 13 patients (21%). There were 55 non-
alcoholics (88.7%) while the alcoholics were 7 (11.3%) (Table 3.1). 
 
Figure (3.1): Age distribution. 
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Figure (3.2): Gender distribution of the patients. 
 
  
Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Toombak 
dipping 
No 20 32.3 32.3 32.3 
Yes 42 67.7 67.7 100.0 
Alcoholism No 55 88.7 88.7 88.7 
Yes 7 11.3 11.3 100.0 
Smoking NO 49 79.0 79.0 79.0 
Yes 
13 
 
21.0 
 
21.0 100.0 
Table (3.1): Distribution of habits among patients 
Site of the Lesion: The most common site for the OED and SCC was the 
gingivolabial (25 lesions, 40.32%) followed by the tongue (12 lesion, 
19.35%), buccal mucosa (11 cases, 17.74%), mandible (6 cases, 9.68%). 
The least common sites were the alveolar mucosa and the labial mucosa 
(4cases, 6.45%) for each (Fig 3.3). 
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The histopathological diagnosis of the lesion: 
 There were 18 cases of moderately differentiated squamous cell 
carcinoma accounting for 29% of the cases. There were 14 cases of well 
differentiated squamous cell carcinoma accounting for 22.6% of the 
cases. There wer 9 cases of mild dysplasia accounting for 14.5% . There 
were  7 cases of moderate ED accounting for11.3 %. There were 5 cases 
for both  verrucous carcinoma and the  poorly differentiated SCC 
accounting for 8.1% each . There were 2 cases of verruciform  
leukoplakia  accounting 3.2% and  lastly there was one case   of 
carcinoma insitu and  another  one of severe ED  accounting for 1.6%  
each (Table 3.2) 
 
Figure (3.3): Site of the Lesions 
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Frequency Percent Valid Percent 
Cumulative 
Percent 
carcinoma insitu 1 1.6 1.6 1.6 
MDSCC 18 29.0 29.0 30.6 
MiED 9 14.5 14.5 45.2 
MoED 7 11.3 11.3 56.5 
PDSCC 5 8.1 8.1 64.5 
SED 1 1.6 1.6 66.1 
verruciform leukoplakia 2 3.2 3.2 69.4 
Verrucous carcinoma 5 8.1 8.1 77.4 
WDSCC 14 22.6 22.6 100.0 
Total 62 100.0 100.0  
Table (3.2): Histopathological diagnosis of the lesions 
 
Site of toombak dipping: 
Twenty nine out of 62 lesions where found in the lower labial vestibule, 
site for toombak dipping, accounting for 69.05% of the cases( table 3.3) . 
Eight patients dip in both upper and lower vestibules and they had 10 
lesions accounting for 16.1 %. There was one case who dip in the area of  
lower labial vestibule with lower buccal vestibule, floor of the mouth 
with the lower labial vestibule and lower buccal vestibue for each (1.6%).  
 
Site 
No. of 
lesions 
No. of 
pateints Percent Valid Percent 
Cumulative 
Percent 
LBV 1 1 1.6 1.6 1.6 
LLV 29 24 46.8 46.8 48.4 
LLV + floor 1 1 1.6 1.6 50.0 
LLV ULV 10 8 16.1 16.1 66.1 
LLV+LBV 1 1 1.6 1.6 67.8 
None dipping 
20 
 
19 
32.3 32.3 100.0 
Total 62 54 100.0 100.0  
Table (3.3): Site of toombak dipping 
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Association of Argyrophilic nucleolar organizer region (AgNOR) 
count with Histopathological diagnosis: 
Analysis of variance (ANOVA) statistical test  showed the mAgNOR 
count increases as the grade of SCC  is increased and this is statistically 
significant (P= 0.0001). The mean AgNOR in verrucous carcinoma was 
5.59±2.26, the mean AgNOR in well differentiated SCC  was 6.1±2.02, 
the mean AgNOR in the moderately differentiated SCC was 9.19 ±2.47,  
and  in the poorly differentiated SCC was16.73 ±5.08) and this is 
statistically significant (p= 0.0001). The mAgNOR showed some 
relationship with the dysplastic lesions, but the number of cases was not 
enough to verify the relationship (Table 3.4). 
Histopathologi
cal diagnosis No. 
Minimu
m 
Maxi
mum Median Mean 
95% confidence 
interval of the 
mean 
Std. 
Deviation 
MDSCC 18 5.54 14.56 8.8000 9.1933 7.9622-10.4245 2.47575 
Mild ED 9 3.00 6.38 3.4800 3.9956 3.0579-4.9333 1.21991 
Moderate ED 7 2.26 7.54 4.1200 4.1600 2.5741-4.7459 1.71472 
PDSCC 5 9.40 21.76 16.1800 16.7360 10.4253-23.0467 5.08243 
Sever ED 1 3.80 3.80 3.8000 3.8000 . . 
Verrucous 
carcinoma 5 3.44 9.14 5.6400 5.5960 
2.7804-8.4116 2.26762 
WDSCC 14 4.14 12.56 5.7900 6.1000 4.9305-7.2695 2.02547 
Carcinoma 
insitu 1 2.78 2.78 2.7800 2.7800 
. . 
verruciform 
leukoplakia 2 3.18 4.64 3.9100 3.9100 
-5.3655-13.1855 
1.03238 
Total 62 2.26 21.76 5.9800 7.1294  4.20301 
(p=0.0001, ANOVA) 
Table (3.4): Association of Argyrophilic nucleolar organizer region 
(AgNOR) count with Histopathological diagnosis. 
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Analysis of the mean AgNOR of dysplasia and SCC in association with 
toombak dipping habit showed that the mAgNOR is increased in non-
toombak dippers in MDSCC, PDSCC, verrucous carcinoma, moderate 
epithelial dysplasia. The reverse was true for WDSCC and this is 
statistically significant (P=0.0001).  A decrease in the proliferative 
activity of OED and SCC was noticed in cases with toombak habit (Table 
3.5). 
Analysis of the mAgNOR in lesions with association to alcohol habit 
showed that the mAgNOR is increased in non alcoholics than in 
alcoholics in MDSCC &WDSCC and the reverse was true for mild ED 
and verrucous carcinoma (Table 3.6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 37 
 
histopathologic
al diagnosi 
toombak 
dipping N Minimum Maximum Median Mean 
Std. 
Deviation 
MDSCC No 9 6.80 14.56 9.7600 10.2311 2.66199 
Yes 9 5.54 10.88 8.1600 8.1556 1.87493 
Total 18 5.54 14.56 8.8000 9.1933 2.47575 
MiED Yes 9 3.00 6.38 3.4800 3.9956 1.21991 
Total 9 3.00 6.38 3.4800 3.9956 1.21991 
MoED No 2 4.12 7.54 5.8300 5.8300 2.41831 
Yes 5 2.26 4.74 3.2800 3.4920 .99806 
Total 7 2.26 7.54 4.1200 4.1600 1.71472 
PDSCC No 3 9.40 21.76 21.3200 17.4933 7.01248 
Yes 2 15.02 16.18 15.6000 15.6000 .82024 
Total 5 9.40 21.76 16.1800 16.7360 5.08243 
SED No 1 3.80 3.80 3.8000 3.8000 . 
Total 1 3.80 3.80 3.8000 3.8000 . 
Verrucous 
carcinoma 
No 1 9.14 9.14 9.1400 9.1400 . 
Yes 4 3.44 5.96 4.7200 4.7100 1.27389 
Total 5 3.44 9.14 5.6400 5.5960 2.26762 
WDSCC No 4 4.82 6.40 6.1600 5.8850 .73073 
Yes 10 4.14 12.56 5.5200 6.1860 2.39147 
Total 14 4.14 12.56 5.7900 6.1000 2.02547 
Carcinoma  
insitu 
Yes 1 2.78 2.78 2.7800 2.7800 . 
Total 1 2.78 2.78 2.7800 2.7800 . 
verruciform 
leukoplakia 
Yes 2 3.18 4.64 3.9100 3.9100 1.03238 
Total 2 3.18 4.64 3.9100 3.9100 1.03238 
Total No 20 3.80 21.76 8.8000 9.6350 4.97598 
Yes 42 2.26 16.18 5.3400 5.9362 3.20737 
Total 62 2.26 21.76 5.9800 7.1294 4.20301 
 
Table (3.5): Association of toombak dipping and AgNOR count in 
different histopathological diagnosis 
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(p=0.0001, ANOVA) 
Table (3.6):  The relationship between alcohol drinking and AgNOR 
count of OED and SCC 
 
 
 
 
 
 
histopathological 
diagnosi Alcholism N Minimum Maximum Median Mean 
Std. 
Deviation 
MDSCC no 16 5.54 14.56 8.8000 9.2612 2.53889 
yes 2 6.80 10.50 8.6500 8.6500 2.61630 
Total 18 5.54 14.56 8.8000 9.1933 2.47575 
MiED no 8 3.00 6.38 3.4800 3.9600 1.29914 
yes 1 4.28 4.28 4.2800 4.2800 . 
Total 9 3.00 6.38 3.4800 3.9956 1.21991 
MoED no 7 2.26 7.54 4.1200 4.1600 1.71472 
Total 7 2.26 7.54 4.1200 4.1600 1.71472 
PDSCC no 5 9.40 21.76 16.1800 16.7360 5.08243 
Total 5 9.40 21.76 16.1800 16.7360 5.08243 
SED no 1 3.80 3.80 3.8000 3.8000 . 
Total 1 3.80 3.80 3.8000 3.8000 . 
Verrucous 
carcinoma 
no 4 3.44 9.14 4.7200 5.5050 2.60785 
yes 1 5.96 5.96 5.9600 5.9600 . 
Total 5 3.44 9.14 5.6400 5.5960 2.26762 
WDSCC no 12 4.14 12.56 6.0200 6.3200 2.11590 
yes 2 4.68 4.88 4.7800 4.7800 .14142 
Total 14 4.14 12.56 5.7900 6.1000 2.02547 
ca insitu yes 1 2.78 2.78 2.7800 2.7800 . 
Total 1 2.78 2.78 2.7800 2.7800 . 
verruciform leukopl no 2 3.18 4.64 3.9100 3.9100 1.03238 
Total 2 3.18 4.64 3.9100 3.9100 1.03238 
Total no 55 2.26 21.76 6.0400 7.3116 4.35639 
yes 7 2.78 10.50 4.8800 5.6971 2.46891 
Total 62 2.26 21.76 5.9800 7.1294 4.20301 
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histopathological 
diagnosi smoking N Minimum Maximum Median Mean Std. Deviation 
MDSCC no 17 5.54 14.56 8.9600 9.3341 2.47656 
yes 1 6.80 6.80 6.8000 6.8000 . 
Total 18 5.54 14.56 8.8000 9.1933 2.47575 
MiED no 6 3.00 6.38 3.5700 3.9733 1.26855 
yes 3 3.02 5.62 3.4800 4.0400 1.38752 
Total 9 3.00 6.38 3.4800 3.9956 1.21991 
MoED no 6 2.26 7.54 4.1800 4.3067 1.82965 
yes 1 3.28 3.28 3.2800 3.2800 . 
Total 7 2.26 7.54 4.1200 4.1600 1.71472 
PDSCC no 5 9.40 21.76 16.1800 16.7360 5.08243 
Total 5 9.40 21.76 16.1800 16.7360 5.08243 
SED no 1 3.80 3.80 3.8000 3.8000 . 
Total 1 3.80 3.80 3.8000 3.8000 . 
Verrucous carcinoma no 4 3.44 9.14 4.7200 5.5050 2.60785 
yes 1 5.96 5.96 5.9600 5.9600 . 
Total 5 3.44 9.14 5.6400 5.5960 2.26762 
WDSCC no 8 4.14 12.56 5.4000 6.2400 2.66529 
yes 6 4.68 7.10 6.0200 5.9133 .80505 
Total 14 4.14 12.56 5.7900 6.1000 2.02547 
Carcinoma  insitu yes 1 2.78 2.78 2.7800 2.7800 . 
Total 1 2.78 2.78 2.7800 2.7800 . 
verruciform 
leukoplakia 
no 2 3.18 4.64 3.9100 3.9100 1.03238 
Total 2 3.18 4.64 3.9100 3.9100 1.03238 
Total no 49 2.26 21.76 6.3800 7.6653 4.52700 
yes 13 2.78 7.10 5.6200 5.1092 1.49315 
Total 62 2.26 21.76 5.9800 7.1294 4.20301 
 
Table (3.7): Association between smoking and AgNOR count of OED 
and SCC 
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There is weak inverse relationship between the mAgNOR and the 
duration of toombak dipping per years (Fig 3.4).  
Using the T-test, the mean difference of the mAgNOR in male and 
female was not statistically significant, (T test, p=0.069) (Table 3.8). 
 
 
Figure (3.4): The relationship between mAgNOR and duration of 
toombak dipping per years. 
 
 
 
 
 Gender
of the pt N Mean Std. Deviation Std. Error Mean 
mAgNOR M 43 6.4847 4.52309 .68976 
F 19 8.5884 2.98152 .68401 
Table (3.8): The association between gender and mAgNOR. 
 
 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 41 
 
4.1 Discussion: 
In the last three decades, the AgNOR technique has been widely used for 
diagnostic as well as for prognostic purposes[70]. AgNOR different 
parameters, including counting, distribution and other morphometric 
analysis, have been studied in human body lesions as well as 
maxillofacial lesions[31-67]. Several studies  regarding  SCC, 
premalignant lesions with or without dysplasia , premalignant conditions 
such as lichen planus and submucous fibrosis, malignant neoplasms, 
reactive lesions, salivary gland lesions and tumors , odontogenic cysts 
and tumors[37-67].  In tumors, AgNORs are used widely to differentiate 
between benign and malignant tumors, and to evaluate the growth 
potential as well as to determine the tumors’ malignant potential [4, 5]. 
The present study showed that AgNOR staining is a simple method that 
can be used as a reliable diagnostic histopathology tool. It was found that 
the mean AgNOR estimates in toombak dippers compared to that in non-
toombak dippers can provide a statistically significant information .The 
finding of the present study showed that lesions from toombak dippers 
are associated with less cellular proliferation than lesions from non-
toombak dippers. Furthermore, the study showed that mAgNOR increases 
significantly along with the histopathological grade of SCC.  
From a methodological point of view, the main question of this study was 
the effect of toombak dipping in the proliferative activity of dysplastic 
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and SCC lesions. Many articles are available on the histopathology of 
SCC and ED using the mean AgNOR. However this is the first 
histopathological study using the mean AgNOR in Oral ED and SCC in 
toombak dippers. 
A cytological study done by Ahmed and Babikir  assessing the cells of 
the normal oral mucosa  and of  the mucosa exposed to toombak and 
smoking, showed that the mAgNOR of  toombak users mucosa  ranged 
between 1 to 9 , while that of the normal mucosa  ranged between 1 to  4.  
The investigators concluded that cellular proliferation in toombak users is 
more rapid than that in non-toombak users[71]. 
The current study showed that there is a relationship between the 
different histopathological grades of SCC that could be detected by the 
mean count of AgNORs, as the mAgNOR has increased along with the 
histopathological grade of SCC. Our results are in accordance with 
studies of Manu et al.[59] and Chatterjee et al.[48] who showed an 
association between AgNOR count and the histopatholoical grade of 
SCC, but it is in contrast to Xin Xie et al. [45] and Fonseca et al. [53] 
who found no relationship between AgNOR count and the 
histopathological grade.  The latter investigators, accordingly, suggested 
that a large study with a large sample size should be carried out, and more 
than one section of tissue should be evaluated for the histopathological 
grading of SCC. 
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The table below shows results from some different studies using 
mAgNOR. Our findings showed similarity to the results of Chaterjee et 
al. [48], but they reveal some differences from the results of Fonseca et 
al. [53], Manu et al. [59] and M.J. Ashraf et al.[67] These differences 
may be due to different staining techniques and variation of the tissue 
section thickness. The quantification method and the protocol followed in 
counting the AgNORs may also have contributed to these differences. 
 WDSCC MDSCC PDSCC 
 No* mAgNOR No mAgNOR No mAgNOR 
Our study 2011 14 6.1±7.07 18 9.19±2.47 5 16.73±5.08 
Chatterjee et al  
1997 
17 5.12±0.82 16 7.31±1.07 6 10.5±0.54 
 Fonseca et al 
2000 
7 6.56±1.25 --- --- 12 7.07±1.60 
Manu et al 2006 27 3.29±1.31 21 4.29±1.59 2 5.21±0.0 
M. J. Ashraf et 
al 2010 
15 1.70±0.34 8 2.10±0.58 3 3.52±0.43 
No*= the number of cases 
Little is known about ED proliferative activity using AgNOR technique 
and most of the authors  used this technique only to differentiate between 
ED and SCC and also between ED and non dysplastic oral lesions. 
However, the grading of ED may be difficult and subjective depending on 
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the histopathologist capability. Chatopadhyay et al. [63] found a cut-point 
to differentiate between mild and moderate ED (agNOR: 2.3).However, 
Khan et al. [72] and Cano et al. [56] found no statistical differences 
between the different grades of ED.  In the present study the number of 
cases of ED was not enough to draw any relationship between its 
different groups. 
An interesting observation is that lesions from toombak dippers showed 
less AgNOR counts compared to lesions from non-toombak dippers. This 
indicates that the cellular proliferation rates at the sites of toombak 
dipping and where the lesions have developed, for a reason or another,  
are somehow lower than expected, making it  necessary to conduct a  
more comprehensive study on the subject. 
In this study the simple conventional counting method of mAgNOR was 
used. The AgNOR reagent was cheap and easily applied. However we 
found the procedure is sensitive and need a high technical standard as 
well as a trained technician.  
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Limitations: 
In the current study there are limitations that should be mentioned.  The 
1st limitation and most important is the technique itself;  although  
AgNOR staining is  a one-step , simple and cost effective  procedure ,it 
needs a lot of dedication, standardization and trained technicians to 
achieve good results. 
The 2nd limitation of this study is the small sample of ED lesions (most of 
these lesions were asymptomatic and discovered on routine examination). 
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4.2 Conclusion: 
The current study showed that SCC and ED associated with toombak 
dipping have less cellular proliferation compared to similar lesions from 
non-toombak dippers. 
The mAgNOR for toombak dippers was statistically different from the 
mAgNOR in non-toombak dippers.  
The mAgNOR increased along with the tumor grade of SCC, being 
highest in the poorely differentiated and lowest in the well differentiated 
SCC and in-between in the moderately differentiated SCC. 
The mAgNOR in epithelial dysplasia was not of statistical significance to 
differentiate between the different grades of the lesion.  
The mean AgNOR count should be used as an adjunct tool in the routine 
histpathology to detect the proliferation rate of ED and SCC. 
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4.3 Recommendations: 
The use of AgNOR method is of value in providing an idea about the 
proliferation of the tumor. Therefore, it is recommended that AgNOR 
technique is to be used as a supportive tool to the routine histopathology. 
The grading of SCC is very subjective so a numerical method should be 
applied as a diagnostic tool to help the clinicians and the pathologists to 
differentiate between the different grades of SCC. The technique gives an 
indication about the proliferative rate of the tumors. 
It is recommended that another study with a larger sample size is to be 
conducted. As well further investigations are needed to assess other 
proliferative markers and proliferative genes to clarify the relation 
between toombak dipping and low proliferation rate in SCC. 
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